These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7732151)

  • 1. [A case of schizophrenia with "uninformed" medication of antipsychotic drug in community--remodeling the concept of "protection" in informed consent].
    Kumakura N
    Seishin Shinkeigaku Zasshi; 1995; 97(2):106-16. PubMed ID: 7732151
    [No Abstract]   [Full Text] [Related]  

  • 2. Documenting informed consent for antipsychotic medication.
    Holzapfel S
    Can Fam Physician; 1999 Jun; 45():1403-4, 1415-6. PubMed ID: 10386200
    [No Abstract]   [Full Text] [Related]  

  • 3. [Patients' perspective on the quality of informed consent into psychopharmacological treatment in schizophrenia and depression].
    Schildmann J; Bauer A; Tilmann A; Vollmann J
    Fortschr Neurol Psychiatr; 2003 May; 71(5):265-70. PubMed ID: 12740758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In that case: Karen is a 31-year-old woman who suffers from schizophrenia and has been treated with an anti-psychotic medication for a number years. Commentary.
    Romans S
    N Z Bioeth J; 2001 Jun; 2(2):34-5. PubMed ID: 15719457
    [No Abstract]   [Full Text] [Related]  

  • 5. In that case: Karen is 31-year-old woman who suffers from schizophrenia and has been treated with an anti-psychotic medication for a number of years. Commentary.
    Kenny G
    N Z Bioeth J; 2001 Jun; 2(2):33-4. PubMed ID: 15719456
    [No Abstract]   [Full Text] [Related]  

  • 6. In that case: Karen is a 31-year-old woman who suffers from schizophrenia and has been treated with an anti-psychotic medication for a number of years. Commentary.
    Cole S
    N Z Bioeth J; 2001 Jun; 2(2):32-3. PubMed ID: 15586998
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia.
    Palmer BW; Dunn LB; Appelbaum PS; Jeste DV
    Arch Gen Psychiatry; 2004 Mar; 61(3):230-6. PubMed ID: 14993110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotics in the treatment of schizophrenia. "Informed relationship between doctor and patient" does not exist in many parts of the world.
    Lee S
    BMJ; 2001 Apr; 322(7291):925-6; author reply 927-8. PubMed ID: 11302915
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Karen.
    Smith M
    N Z Bioeth J; 2002 Jun; 3(2):27-8. PubMed ID: 15587496
    [No Abstract]   [Full Text] [Related]  

  • 10. Legal fallacies of antipsychotic drugs.
    Erickson SK; Ciccone JR; Schwarzkopf SB; Lamberti JS; Vitacco MJ
    J Am Acad Psychiatry Law; 2007; 35(2):235-46. PubMed ID: 17592170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed consent for antipsychotic medication.
    Schachter D; Kleinman I; Williams JI
    Can Fam Physician; 1999 Jun; 45():1502-8. PubMed ID: 10386214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription pattern of antipsychotic drugs for schizophrenic inpatients in Japan: research on East Asia Psychotropic Prescription Pattern-Antipsychotics study.
    Yoshimura R; Okamoto T; Nakamura J; Tateno M; Otsuka K; Takahashi H; Fujisawa D; Takamatsu T; Fujii S; Sato S; Inoue M; Sasaki H; Kuroki T; Shinfuku N
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):778-9. PubMed ID: 17109719
    [No Abstract]   [Full Text] [Related]  

  • 13. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic medication adherence in schizophrenia.
    Byerly MJ; Nakonezny PA; Lescouflair E
    Psychiatr Clin North Am; 2007 Sep; 30(3):437-52. PubMed ID: 17720031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results.
    Haro JM; Suarez D; Novick D; Brown J; Usall J; Naber D;
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):235-44. PubMed ID: 17137759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Informed consent requirement in treatment with clozapine according to section 1904 of the patient rights law?].
    Dose M
    Nervenarzt; 1994 Nov; 65(11):787-91. PubMed ID: 7816156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of conventional antipsychotic medications for patients with schizophrenia in a medicaid population: therapeutic and cost outcomes over 2 years.
    McCombs JS; Luo M; Johnstone BM; Shi L
    Value Health; 2000; 3(3):222-31. PubMed ID: 16464186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adherence to antipsychotic medication in schizophrenia patients].
    Baloush-Kleinman V; Poyurovsky M; Koren D; Schneidman M; Weizman A; Shnitt D
    Harefuah; 2002 Dec; 141(12):1042-9, 1090. PubMed ID: 12534202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.